McMaster University

John Boden To Bring Valuable Expertise and Leadership to i2k Connect, an AI Software Company

Retrieved on: 
Tuesday, October 3, 2023
Connect, Society, Society of Petroleum Engineers, Senior, Telecommunications, Product innovation, Petroleum engineering, McMaster University, Physics, Growth, SaskTel, R, Corporate development, Management, Engineering

HOUSTON, Oct. 3, 2023 /PRNewswire-PRWeb/ -- i2k Connect welcomes John Boden to its team as Senior Vice President of Corporate Development. John's focus is expanding the company's footprint in existing and new market segments.

Key Points: 
  • i2k Connect welcomes John Boden, a technology, energy, and telecom expert to its team.
  • HOUSTON, Oct. 3, 2023 /PRNewswire-PRWeb/ -- i2k Connect welcomes John Boden to its team as Senior Vice President of Corporate Development.
  • "John's experience in startups and corporate development will make him a vital part of i2k Connect.
  • Prior to joining i2k Connect, John was Vice President of Information and Member Services at the Society of Petroleum Engineers.

Aura Biosciences Strengthens and Expands Leadership Team with Key Appointments

Retrieved on: 
Monday, October 2, 2023
Research, FDA, Clinical Trials, Biotechnology, Health, Pharmaceutical, Optical, Science, Oncology, University of Southern California, Canada, Royal college, Research and development, Central nervous system, University, American Board of Ophthalmology, Retina, Education, Senior, Lysogenic cycle, Cancer, Visual impairment, Record, Life Technologies, AstraZeneca, University of Belgrade, American Board of Commissioners for Foreign Missions, Moorfields Eye Hospital, Novartis, McMaster University, Patient, VDC, RAC, Growth, Immunology, Regulatory affairs, American College, Therapy, Roche, Eye disease, Pharmaceutical industry, Microbiology, Virology, Ophthalmology

“Jill and Mark’s appointments come at an important time in Aura’s evolution as a late stage clinical development company,” said Elisabet de los Pinos, Ph.D., Chief Executive Officer of Aura.

Key Points: 
  • “Jill and Mark’s appointments come at an important time in Aura’s evolution as a late stage clinical development company,” said Elisabet de los Pinos, Ph.D., Chief Executive Officer of Aura.
  • “We have built our leadership team with experienced industry leaders who have proven track records of success with multiple drug approvals.
  • Dr. Hopkins is board certified in Ophthalmology from the American Board of Ophthalmology and the Royal College of Surgeons Canada.
  • Before joining Sanofi Genzyme, Dr. Plavsic held various technical leadership positions with AstraZeneca, Q-One Biotech, and Life Technologies.

EQB announces appointment of Chief Risk Officer

Retrieved on: 
Monday, October 2, 2023
BMO, Science, University, Bank of Montreal, Engineering, Schulich School of Business, Toronto, Business, Risk management, Dean, MBA, University of Ottawa Heart Institute, Enterprise risk management, Chemical substance, McMaster University, Faculty, TSX, Bank, Equitable Bank, Chemical engineering, EQB, Management

TORONTO, Oct. 2, 2023 /PRNewswire/ - EQB Inc. (TSX: EQB) (TSX: EQB.PR.C) and its wholly owned subsidiary Equitable Bank (the "Bank"), are pleased to announce that Marlene Lenarduzzi will be joining the Bank as its Chief Risk Officer on October 10, 2023.

Key Points: 
  • TORONTO, Oct. 2, 2023 /PRNewswire/ - EQB Inc. (TSX: EQB) (TSX: EQB.PR.C) and its wholly owned subsidiary Equitable Bank (the "Bank"), are pleased to announce that Marlene Lenarduzzi will be joining the Bank as its Chief Risk Officer on October 10, 2023.
  • She comes to the Bank following more than 25 years of experience in risk management and banking with depth in strategy development, regulatory relationships, risk quantification, operations, and execution.
  • Prior to joining EQB, Ms. Lenarduzzi was Head, Counterparty Credit Risk Management and Market Risk Strategic Initiatives at BMO Financial Group.
  • Ms. Lenarduzzi will lead the Bank's risk department and will be the head of its Enterprise Risk Management function with responsibility for credit, operational and enterprise risk.

Acuity Insights named one of Canada’s top growing companies by The Globe and Mail Report on Business

Retrieved on: 
Friday, September 29, 2023
Grace Medes, Empathy, Growth, Research, McMaster University, Education, Nursing, Acuity

TORONTO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Acuity Insights announces that it has been placed in The Globe and Mail’s list of Canada’s Top Growing Companies which ranks Canadian companies on three-year revenue growth.

Key Points: 
  • TORONTO, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Acuity Insights announces that it has been placed in The Globe and Mail’s list of Canada’s Top Growing Companies which ranks Canadian companies on three-year revenue growth.
  • Acuity Insights strives to help uncover and nurture everyone’s full potential by offering innovative products, services, and insights that drive holistic success.
  • "Being recognized by The Globe and Mail as one of Canada's rapidly growing companies is a great honour for our team at Acuity Insights.
  • Sharing this recognition with other trail-blazing businesses throughout the country is truly a privilege," says Rich Emrich, CEO of Acuity Insights.

Avaya's Momentum in Canada Continues to Build

Retrieved on: 
Thursday, September 21, 2023
Telecommunications, Software, Networks, Internet, Artificial Intelligence, Data Management, Technology, VoIP, Cloud, Insurance, Hydro Ottawa, 5G Automotive Association, Ottawa Police Service, CCTC, Estradiol/norethisterone, McMaster University, Investment, Pedigree, PSAP, Kareem, Government, Federation, Geography, Product management, Bell, Information technology consulting, Human, Research, Consultant, United Nations Convention on Contracts for the International Sale of Goods, Public sector, Organization, Growth, Shared Services Canada, Communications and Utilities Regulatory Authority, GVP, Communication, ChatGPT, Generator, Public security, Acadia University, Tire, CRTC, CAA, Education, CX, WebRTC, Associate, Artificial intelligence, AI, Sales, Network equipment provider, Avaya

Avaya , a global leader in customer experience solutions, discussed market momentum in one of its most important markets – Canada.

Key Points: 
  • Avaya , a global leader in customer experience solutions, discussed market momentum in one of its most important markets – Canada.
  • During the event, Robertson highlighted the company’s work in Canada across key industries such as public sector, finance, insurance, retail, education, and healthcare.
  • Progress in cloud comes alongside momentum in Avaya Experience Platform™ , which offers an AI-powered, contact centre-as-a-service collaboration platform.
  • It’s a great reminder of how extensive Avaya’s presence is in Canada, and based on their recent performance, that presence is clearly growing.”

Insight Medbotics Announces World's First FDA-Cleared, MRI-Compatible Robot

Retrieved on: 
Wednesday, September 13, 2023
Field line, McMaster Institute of Environment and Health, Network, Quality of life, NEPAD African Western and Southern Networks of Centres of Excellence in Water Sciences, Research, Canadian government scientific research organizations, MRI, McMaster University, Patient, Physician, NCE, Medicine, St. Joseph's Healthcare Hamilton, Artificial intelligence, Insulin, FDA, MDA, Robotics, Regulation of tobacco by the U.S. Food and Drug Administration, Safety, Environment, Education, Food, Medical imaging, Medical device, Pharmaceutical industry

IGAR is the first and only robotics system designed to work inside an MRI bore to achieve this regulatory clearance.

Key Points: 
  • IGAR is the first and only robotics system designed to work inside an MRI bore to achieve this regulatory clearance.
  • Insight Medbotics has demonstrated IGAR's safety and efficacy through published clinical studies in breast biopsy.
  • Insight Medbotics was subsequently launched as a start-up company by CSii and MDA.
  • With the 510(k) clearance secured, Insight Medbotics will continue to advance IGAR to market.

New Post Hoc Analysis Showed Substantial Improvement in Observed Estimated Glomerular Filtration Rate (eGFR), in TransCon PTH-Treated Adults with Hypoparathyroidism

Retrieved on: 
Tuesday, September 5, 2023
Kidney, Week, Pathway, Edema, EGFR, Hypoparathyroidism, Weakness, Glomerular filtration rate, PTH, Hypertension, McMaster University, Patient, Southern Transcon, Parathyroid hormone, Pharmaceutical industry, Medicine

COPENHAGEN, Denmark, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new post hoc analysis showing adults with hypoparathyroidism treated with TransCon PTH demonstrated substantial improvement in estimated glomerular filtration rate (eGFR), suggesting improved kidney function. TransCon PTH (palopegteriparatide) is an investigational prodrug of parathyroid hormone (PTH 1-34) administered once daily designed to provide sustained release of active PTH within the physiological range for 24 hours per day in adult patients with hypoparathyroidism.

Key Points: 
  • - Approximately 50% of Phase 3 PaTHway Trial patients with eGFR
  • COPENHAGEN, Denmark, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new post hoc analysis showing adults with hypoparathyroidism treated with TransCon PTH demonstrated substantial improvement in estimated glomerular filtration rate (eGFR), suggesting improved kidney function.
  • “Chronic kidney disease is one of the most consequential complications of chronic hypoparathyroidism and its treatment with conventional therapy.
  • By Week 52, patients treated with TransCon PTH, including those crossing over from placebo, experienced a mean increase in eGFR of 8.9 mL/min/1.73m2 compared to baseline (p

Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update

Retrieved on: 
Tuesday, August 29, 2023
The Angiogenesis Foundation, Senior, Litre, Urine, Symrise, Clinical trial, MBA, Coenzyme Q10, Regulation and licensure in engineering, Trial of the century, YBG, Special Operations Executive, Regeneration, American Thoracic Society, McMaster University, Blood, Pharmacy, Growth, AVS, Dubai Health Authority, CZO, Safety, Wound healing, Pharmaceutical industry, Management, Dietary supplement, Medical device, Ready-mix concrete, Fine chemical, Cryptocurrency

EDMONTON, Alberta, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the second quarter and six months ended June 30, 2023.

Key Points: 
  • Further, over the past quarter we remained very active with our activities related to strategic corporate initiatives.
  • Stability studies are ongoing for the 30mg and 240mg pills formulation manufactured, packaged and labeled by Corealis Inc. GMP Manufacturing Services.
  • Studies showed statistically significant results characterizing the bioactivity of both Ceapro’s oat-derived bioactive products on wound healing and tissue regeneration.
  • Financial Highlights for the Second Quarter and the Six-Month Period Ended June 30, 2022
    Sales of $1,869,000 for the second quarter of 2023 and $5,364,000 for the first six months of 2023 compared to $5,500,000 and $11,672,000 for the comparative periods in 2022.

Hamilton collaboration transforms the future of medical imaging

Retrieved on: 
Thursday, August 24, 2023
Medical imaging, GE HealthCare, Faculty, Learning, IRC, Partnership, Education, Teaching, CERF, McMaster Faculty of Science, Mohawk College, GE, Interprofessional education, Research, McMaster, Government, Google Images, Hamilton Health Sciences, MRI, Student, Magnetic resonance imaging, McMaster University, Patient, Community service, School, Artificial intelligence, Integration, Nursing, Hospital, Science, Health

Hamilton, ON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mohawk College and McMaster University announced today the opening of the Centre for Integrated and Advanced Medical Imaging (CIAMI), a new facility for educational training, imaging research, and increased magnetic resonance imaging (MRI) access for patient care.

Key Points: 
  • Hamilton, ON, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mohawk College and McMaster University announced today the opening of the Centre for Integrated and Advanced Medical Imaging (CIAMI), a new facility for educational training, imaging research, and increased magnetic resonance imaging (MRI) access for patient care.
  • In addition to education and research components, CIAMI partners with the affiliated academic hospital systems, Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton.
  • CIAMI brings technology and healthcare together in Hamilton to propel advancements in imaging research.
  • The new Centre for Integrated and Advanced Medical Imaging will create even more learning and research opportunities for our students and faculty members while also addressing a real need in our community for timely imaging service."

Apogee Minerals Announces Appointment of New Interim CEO

Retrieved on: 
Monday, August 14, 2023
Chartered Professional Accountant, Interim, UBC Sauder School of Business, University, CMA, Business, OTCQB, ASX, MBA, McMaster University, Columbia, CPA, CFO, TSX, Management, Apsis, Finance

Vancouver, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company”) (TSXV: APMI) is pleased to announce the appointment of Mr. Tim Fernback as Interim President and Chief Executive Officer.

Key Points: 
  • Vancouver, British Columbia, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company”) (TSXV: APMI) is pleased to announce the appointment of Mr. Tim Fernback as Interim President and Chief Executive Officer.
  • Mr. Fernback remains the CFO for Apogee.
  • Tim Fernback holds a Chartered Professional Accounting designation (CPA, CMA) and is an active member of the CPA of British Columbia and other industry associations within Canada.
  • James Pettit has been appointed as Executive Chairman will remain a Director of Apogee.